Skip to content
You can now search across every topic, entity and event.What's new
Timeline

CellCentric

UK biotech developing inobrodib for multiple myeloma; Europe's largest private biotech round in 2026.

2 of 2 entries (2 events, 0 interactions)

Filters
#45 May

Closed oversubscribed $220m Series D to fund Phase 2 DOMMINO-1 trials for inobrodib in multiple myeloma

UK Startups and Innovation: CellCentric raises Europe's largest 2026 biotech round